Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 45.43%17.75B | 36.86%11.03B | 42.86%5.5B | 12.31%17.35B | 4.34%12.2B | 2.60%8.06B | -4.18%3.85B | -8.79%15.45B | -8.10%11.7B | -10.58%7.86B |
| Operating income | 45.43%17.75B | 36.86%11.03B | 42.86%5.5B | 12.31%17.35B | 4.34%12.2B | 2.60%8.06B | -4.18%3.85B | -8.79%15.45B | -8.10%11.7B | -10.58%7.86B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Selling expenses | 3.85%-75M | 7.55%-49M | 22.22%-21M | 6.67%-126M | 6.02%-78M | -3.92%-53M | -8.00%-27M | -4.65%-135M | -5.06%-83M | -2.00%-51M |
| Employee expense | -3.53%-2.96B | -0.77%-1.95B | 4.37%-964M | -9.03%-3.89B | -10.64%-2.86B | -13.21%-1.94B | -15.86%-1.01B | -7.22%-3.56B | -3.48%-2.59B | -2.64%-1.71B |
| Depreciation and amortization | -7.76%-1.13B | -6.45%-743M | -3.77%-358M | 2.84%-1.4B | 3.42%-1.04B | 2.92%-698M | 5.48%-345M | 1.10%-1.44B | -0.84%-1.08B | -0.28%-719M |
| Special items of operating profit | 5.68%2.46B | 19.95%1.91B | -16.80%743M | -4.38%2.95B | -8.47%2.32B | -9.87%1.59B | -18.00%893M | 1,141.22%3.08B | 429.18%2.54B | 360.41%1.76B |
| Operating profit | 52.13%16.04B | 46.43%10.2B | 45.71%4.9B | 11.16%14.88B | 0.56%10.54B | -2.48%6.96B | -12.59%3.36B | 14.15%13.39B | 26.22%10.48B | 25.77%7.14B |
| Financing cost | 16.28%-72M | 16.95%-49M | 16.67%-25M | 15.56%-114M | 15.69%-86M | 15.71%-59M | 14.29%-30M | 2.17%-135M | 2.86%-102M | 4.11%-70M |
| Share of profit from joint venture company | -69.44%22M | -64.58%17M | -69.23%8M | 7.32%88M | 14.29%72M | 23.08%48M | 30.00%26M | 15.49%82M | 12.50%63M | -7.14%39M |
| Earning before tax | 51.86%15.99B | 46.20%10.16B | 45.38%4.88B | 11.41%14.85B | 0.80%10.53B | -2.21%6.95B | -12.35%3.36B | 14.35%13.33B | 26.50%10.45B | 25.91%7.11B |
| Tax | -113.87%-2.51B | -109.14%-1.6B | -120.00%-781M | -25.68%-1.7B | -7.40%-1.18B | -3.37%-766M | 9.67%-355M | 13.62%-1.35B | 5.69%-1.09B | 9.30%-741M |
| After-tax profit from continuing operations | 44.07%13.48B | 38.41%8.56B | 36.55%4.1B | 9.80%13.16B | 0.03%9.35B | -2.86%6.19B | -12.66%3B | 18.68%11.98B | 31.76%9.35B | 31.87%6.37B |
| Earning after tax | 44.07%13.48B | 38.41%8.56B | 36.55%4.1B | 9.80%13.16B | 0.03%9.35B | -2.86%6.19B | -12.66%3B | 18.68%11.98B | 31.76%9.35B | 31.87%6.37B |
| Minority profit | -32.14%57M | -29.51%43M | -32.26%21M | -11.76%105M | -2.33%84M | 8.93%61M | 10.71%31M | 600.00%119M | 4,400.00%86M | 900.00%56M |
| Profit attributable to shareholders | 44.76%13.42B | 39.09%8.52B | 37.27%4.08B | 10.02%13.05B | 0.05%9.27B | -2.96%6.13B | -12.85%2.97B | 17.70%11.86B | 30.51%9.27B | 30.52%6.31B |
| Basic earnings per share | 44.88%10.62 | 39.26%6.74 | 37.45%3.23 | 10.14%10.32 | 0.14%7.33 | -3.01%4.84 | -12.64%2.35 | 17.71%9.37 | 30.48%7.32 | 30.63%4.99 |
| Diluted earnings per share | 44.87%10.59 | 39.13%6.72 | 37.61%3.22 | 9.94%10.29 | 0.00%7.31 | -3.01%4.83 | -13.01%2.34 | 17.74%9.36 | 30.54%7.31 | 30.37%4.98 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.